Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Treg Modulation With CD28 and IL-6 Receptor Antagonists

National Institute of Allergy and Infectious Diseases (NIAID) · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
living
living-donor kidney transplant, kidney transplant recipients, adult living-donor kidney transplant recipients, novel immunosuppressive (is) therapy regimen, lulizumab pegol (bms-931699), cd28 and il-6 biologic blockade, cd28 and il-6 receptor antagonists, t regulatory cells (treg) modulation, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 993218
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.